Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvement in exercise duration, lung function and well-being in G551D-cystic fibrosis patients: a double-blind, placebo-controlled, randomized, cross-over study with ivacaftor treatment.
Edgeworth D, Keating D, Ellis M, Button B, Williams E, Clark D, Tierney A, Heritier S, Kotsimbos T, Wilson J. Edgeworth D, et al. Among authors: williams e. Clin Sci (Lond). 2017 Jul 16;131(15):2037-2045. doi: 10.1042/CS20170995. Print 2017 Aug 1. Clin Sci (Lond). 2017. PMID: 28611235 Clinical Trial.
Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension.
King SJ, Tierney AC, Edgeworth D, Keating D, Williams E, Kotsimbos T, Button BM, Wilson JW. King SJ, et al. Among authors: williams e. Nutrition. 2021 May;85:111124. doi: 10.1016/j.nut.2020.111124. Epub 2021 Feb 8. Nutrition. 2021. PMID: 33571868 Clinical Trial.
The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosis.
Button BM, Wilson LM, Burge AT, Kimmel L, Finlayson F, Williams E, Talbot A, Tierney A, King S, Holland AE, Keating D, Kotsimbos T, Wilson JW. Button BM, et al. Among authors: williams e. ERJ Open Res. 2021 Sep 20;7(3):00120-2021. doi: 10.1183/23120541.00120-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34549047 Free PMC article.
Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.
Yapa SWS, Li J, Patel K, Wilson JW, Dooley MJ, George J, Clark D, Poole S, Williams E, Porter CJ, Nation RL, McIntosh MP. Yapa SWS, et al. Among authors: williams e. Antimicrob Agents Chemother. 2014 May;58(5):2570-9. doi: 10.1128/AAC.01705-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550334 Free PMC article. Clinical Trial.
Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.
Truong DT, Trachtenberg FL, Hu C, Pearson GD, Friedman K, Sabati AA, Dionne A, Oster ME, Anderson BR, Block J, Bradford TT, Campbell MJ, D'Addese L, Dummer KB, Elias MD, Forsha D, Garuba OD, Hasbani K, Hayes K, Hebson C, Jone PN, Krishnan A, Lang S, McCrindle BW, McHugh KE, Mitchell EC, Morrison T, Muniz JC, Payne RM, Portman MA, Russell MW, Sanil Y, Shakti D, Sharma K, Shea JR, Sykes M, Shekerdemian LS, Szmuszkovicz J, Thacker D, Newburger JW; MUSIC Study Investigators. Truong DT, et al. JAMA Pediatr. 2025 Jan 13. doi: 10.1001/jamapediatrics.2024.5466. Online ahead of print. JAMA Pediatr. 2025. PMID: 39804656
Cancer Research in the Age of Spatial Omics: Lessons from IMAXT.
Bressan D; IMAXT Cancer Grand Challenges Consortium; Walton N, Hannon GJ; IMAXT Cancer Grand Challenges Consortium. Bressan D, et al. Cancer Discov. 2025 Jan 13;15(1):16-21. doi: 10.1158/2159-8290.CD-24-1686. Cancer Discov. 2025. PMID: 39801241
Commutability assessment of new standard reference materials (SRMs) for determining serum total 25-hydroxyvitamin D using ligand binding and liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays.
Wise SA, Cavalier É, Lukas P, Peeters S, Le Goff C, Briggs LE, Williams EL, Mineva E, Pfeiffer CM, Vesper H, Popp C, Beckert C, Schultess J, Wang K, Tourneur C, Pease C, Osterritter D, Fischer R, Saida B, Dou C, Kojima S, Weiler HA, Bielecki A, Pham H, Bennett A, You S, Ghoshal AK, Wei B, Vogl C, Freeman J, Parker N, Pagliaro S, Cheek J, Li J, Tsukamoto H, Galvin K, Cashman KD, Liao HC, Hoofnagle AN, Budd JR, Kuszak AJ, Boggs ASP, Burdette CQ, Hahm G, Nalin F, Camara JE. Wise SA, et al. Among authors: williams el. Anal Bioanal Chem. 2025 Jan 10. doi: 10.1007/s00216-024-05699-7. Online ahead of print. Anal Bioanal Chem. 2025. PMID: 39789379
Sepsis subtypes and differential treatment response to vitamin C: biological sub-study of the LOVIT trial.
Rynne J, Mosavie M, Masse MH, Ménard J, Battista MC, Maslove DM, Del Sorbo L, St-Arnaud C, DAragon F, Fox-Robichaud A, Charbonney E, Adhikari NKJ, Lamontagne F, Shankar-Hari M; LOVIT Investigators, the Canadian Critical Care Trials Group. Rynne J, et al. Intensive Care Med. 2025 Jan 7. doi: 10.1007/s00134-024-07733-9. Online ahead of print. Intensive Care Med. 2025. PMID: 39774855
5,782 results